Care processes in people in remission from type 2 diabetes: A cohort study using the National Diabetes Audit

被引:4
作者
Holman, Naomi [1 ,10 ]
Khunti, Kamlesh [2 ]
Wild, Sarah H. [3 ]
Sattar, Naveed [1 ]
Knighton, Peter [4 ]
Young, Bob [5 ]
Gregg, Edward W. [6 ]
Bakhai, Chirag [7 ]
Valabhji, Jonathan [7 ,8 ,9 ]
机构
[1] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Scotland
[2] Univ Leicester, Diabet Res Ctr, Leicester, England
[3] Univ Edinburgh, Usher Inst, Coll Med & Vet Med, Edinburgh, Scotland
[4] NHS Digital, Leeds, England
[5] Diabet UK, London, England
[6] Imperial Coll London, Sch Publ Hlth, London, England
[7] NHS England & NHS Improvement, London, England
[8] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Diabet & Endocrinol, London, England
[9] Imperial Coll London, Div Metab Digest & Reprod, London, England
[10] Imperial Coll London, Sch Publ Hlth, London W12 7TA, England
关键词
remission; routine care; type; 2; diabetes; INTENSIVE LIFE-STYLE; BARIATRIC SURGERY; INTERVENTION; ASSOCIATION;
D O I
10.1111/dme.15016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsPeople with type 2 diabetes can enter remission but may relapse or develop legacy complications. This analysis assesses whether people with remission from type 2 diabetes continue receiving annual care processes recommended in national guidelines and the potential impacts of formal recognition of remission. MethodsPeople with type 2 diabetes with and without formal recognition (diagnostic code) of remission, and with and without evidence of remission (HbA(1c) < 48 mmol/mol without prescription for glucose-lowering drugs in preceding 26 weeks), included in the 2018/19 National Diabetes Audit (NDA) for England and Wales were followed up to identify care processes received between 1 January 2019 and 31 March 2020. ResultsOf the 2,822,145 people with type 2 diabetes in the cohort, 16,460 (0.58%) were coded with remission in the 2018/19 NDA. After adjustment for age, sex, socioeconomic deprivation and ethnicity, people coded with remission were less likely to receive each care process than those without such coding irrespective of HbA(1c) measurements (relative risk (RR) of receiving all 8 care processes 0.70 (95% CI 0.69-0.72)). For the 339,235 people with evidence of remission, irrespective of diagnostic coding compared to those without such evidence, the RR for receiving all 8 care processes was 0.94 (95% CI 0.93-0.94). ConclusionsPeople coded with remission of type 2 diabetes were less likely to receive diabetes care processes than those without such coding. People with evidence of remission had only a slightly reduced likelihood of receiving care processes. Formal recognition of remission may affect the provision or uptake of care processes.
引用
收藏
页数:8
相关论文
共 50 条
[41]   Incidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging Study [J].
Karter, Andrew J. ;
Nundy, Shantanu ;
Parker, Melissa M. ;
Moffet, Howard H. ;
Huang, Elbert S. .
DIABETES CARE, 2014, 37 (12) :3188-3195
[42]   Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study [J].
Li, Chia-Ing ;
Liu, Chiu-Shong ;
Lin, Wen-Yuan ;
Meng, Nai-Hsin ;
Chen, Ching-Chu ;
Yang, Sing-Yu ;
Chen, Hsuan-Ju ;
Lin, Cheng-Chieh ;
Li, Tsai-Chung .
JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (07) :1338-1346
[43]   Association of Family History of Type 2 Diabetes with Prostate Cancer: A National Cohort Study [J].
Ji, Jianguang ;
Sundquist, Jan ;
Sundquist, Kristina .
FRONTIERS IN ONCOLOGY, 2016, 6
[44]   Duration of diabetes-related complications and mortality in type 1 diabetes: a national cohort study [J].
Bjerg, Lasse ;
Gudbjornsdottir, Soffia ;
Franzen, Stefan ;
Carstensen, Bendix ;
Witte, Daniel R. ;
Jorgensen, Marit E. ;
Svensson, Ann-Marie .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 (04) :1250-1259
[45]   Type 2 diabetes remission trajectories and variation in risk of diabetes complications: A population-based cohort study [J].
Dambha-Miller, Hajira ;
Hounkpatin, Hilda O. ;
Stuart, Beth ;
Farmer, Andrew ;
Griffin, Simon .
PLOS ONE, 2023, 18 (08)
[46]   Serum glycated albumin as good biomarker for predicting type 2 diabetes: A retrospective cohort study of China National Diabetes and Metabolic Disorders Survey [J].
Bai, Yuanyuan ;
Fang, Yujie ;
Ming, Jie ;
Wei, Huigang ;
Zhang, Pinghua ;
Yan, Juan ;
Du, Yongfeng ;
Li, Qiaoyue ;
Yu, Xinwen ;
Guo, Minglan ;
Liang, Shengru ;
Hu, Ruofan ;
Ji, Qiuhe .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (01)
[47]   Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study [J].
Manski-Nankervis, Jo-Anne ;
Thuraisingam, Sharmala ;
Sluggett, Janet K. ;
Kilov, Gary ;
Furler, John ;
O'Neal, David ;
Jenkins, Alicia .
BMC FAMILY PRACTICE, 2019, 20 (1)
[48]   A 360° Approach to Personalize Lifestyle Treatment in Primary Care for People With Type 2 Diabetes: Feasibility Study [J].
Harakeh, Zeena ;
de Hoogh, Iris ;
Krijger-Dijkema, Anne-Margreeth ;
Berbee, Susanne ;
Kalkman, Gino ;
van Empelen, Pepijn ;
Otten, Wilma .
JMIR FORMATIVE RESEARCH, 2024, 8
[49]   Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry [J].
Hallstrom, Sara ;
Svensson, Ann-Marie ;
Pivodic, Aldina ;
Olafsdottir, Arndis F. ;
Londahl, Magnus ;
Wedel, Hans ;
Lind, Marcus .
DIABETOLOGIA, 2021, 64 (12) :2751-2761
[50]   Global status and trends in type 2 diabetes remission from 2002 to 2022: A bibliometric and visual analysis [J].
Liu, Yang ;
Gang, Xiao-Kun ;
Gao, Yuan ;
Wang, Ying-Xuan ;
Wang, Gui-Xia .
MEDICINE, 2025, 104 (18)